未登录

G

Gema Requena

GlaxoSmithKline

H指数:9

被引数:231

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Initiation in Japanese Patients with Asthma Previously on Inhaled Corticosteroid/Long-Acting β2-Agonist Therapy: A Retrospective Cohort Study

富马酸氟替卡松/乌美溴铵/维兰特罗在日本哮喘患者中的真实世界初始疗效：一项回顾性队列研究（此前接受吸入性糖皮质激素/长效β2激动剂治疗者）

JOURNAL OF CLINICAL MEDICINE

IF2.9

2025-04-090

OA

Overcoming time-varying confounding in self-controlled case series with active comparators: application and recommendations

使用主动比较器克服自控病例系列中的时变混淆: 应用和建议

AMERICAN JOURNAL OF EPIDEMIOLOGY

IF4.8

2024-07-193

OAAI

Validation of an EMR derived algorithm to identify moderate asthma exacerbations in the UK

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

Persistence to inhaled long-acting maintenance therapy in patients with COPD in UK routine clinical practice

在英国常规临床实践中，COPD患者持续吸入长效维持治疗

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

IMPACT OF THE CORONAVIRUS DISEASE 2019 PANDEMIC ON RESPIRATORY MEDICATION DISPENSING IN ASTHMA IN THE UNITED STATES (2018-2022): A POPULATION-BASED STUDY

IF8.6

2023-10-010

PRE

IMPACT OF CORONAVIRUS DISEASE 2019 ON ADHERENCE TO CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASTHMA MAINTENANCE MEDICATIONS IN THE UNITED STATES

IF8.6

2023-10-010

PRE

IMPACT OF THE CORONAVIRUS DISEASE 2019 PANDEMIC ON RESPIRATORY MEDICATION DISPENSING IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE UNITED STATES: A POPULATION-BASED STUDY

IF8.6

2023-10-010

OA

IMPACT OF THE CORONAVIRUS DISEASE 2019 PANDEMIC ON LUNG FUNCTION TESTING IN THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASTHMA POPULATION: A POPULATION-BASED STUDY

IF8.6

2023-10-010

OA

Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β2-agonist dual therapy in a primary care setting in England

BMJ OPEN RESPIRATORY RESEARCH

IF3.4

2022-09-281

OAAI

Disease burden of primary biliary cholangitis and associated pruritus based on a cross-sectional US claims analysis

BMJ OPEN GASTROENTEROLOGY

IF2.9

2022-08-168

OAAI

Clinical Profile and Treatment in Hypereosinophilic Syndrome Variants: A Pragmatic Review

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

IF6.6

2022-08-0132

OAAI

Characteristics and treatment pathways of patients with COPD receiving an inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) in the UK

EUROPEAN RESPIRATORY JOURNAL

IF21

2021-11-251

PRE

Characteristics and treatment pathways of patients with COPD receiving a long-acting muscarinic antagonist/long-acting β2-agonist (LABA/LAMA) in the UK

EUROPEAN RESPIRATORY JOURNAL

IF21

2021-11-250

PRE

The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom

IMMUNITY INFLAMMATION AND DISEASE

IF2.7

2021-07-2211

OAAI

Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term risk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study

INTERNATIONAL JOURNAL OF CARDIOLOGY

IF3.2

2017-06-0129

OAAI